Skip to main content

Table 2 Pre- and post-BoNT-A injection outcome measures for the intrinsic and reflexive contributions to ankle joint resistance (N = 9)

From: Examining the role of intrinsic and reflexive contributions to ankle joint hyper-resistance treated with botulinum toxin-A

 

T0 (Week 0)

T1 (Week 6)

T2 (Week 12)

Friedman test

MAS (-)

1.5 [1,1.6]

1 [0,1.1]*

1 [1,1.6]

p = 0.03

Fast SPAT \(W_{fast}\) (Nm/kg)

0.096 [0.059,0.148]

0.071 [0.045,0.095]

0.062 [0.049,0.091]

p = 0.48

Tardieu \(TS_Q\) (-)

4 [2.5 4]

3 [2.75,3.25]

3 [2,4]

p = 0.52

Diff. SPAT \({\Delta }W\) (Nm/kg)

0.052 [0.017,0.086]

0.022 [0.015,0.052]

0.022 [0.014,0.034]

p = 0.003

Refl. Gain G (Nm\(\cdot\)s/rad)

31 [1.5,40]

14 [4.9,35]

13 [5.5,40]

p = 0.31

Slow SPAT \(W_{slow}\) (Nm/kg)

0.044 [0.031,0.069]

0.039 [0.028,0.060]

0.038 [0.030,0.061]

p = 0.26

Intr. Stiffness K (Nm/rad)

46 [37,74]

40 [32,48]

37 [31,44]

p = 0.67

  1. The median [25th, 75th percentile] across participants are reported. Longitudinal differences across all sessions were evaluated using the Friedman test. Significant Friedman tests (\({\Delta }W\), MAS) were investigated using a multiple comparisons test adjusted with the Bonferonni correction. Sessions with a significant difference compared with week 0 are indicated (*)